Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.55 | N/A |
| PEG Ratio (TTM) | -2.30 | N/A |
| P/S Ratio (TTM) | 1.62 | N/A |
| P/B Ratio (TTM) | 4.28 | N/A |
| P/FCF Ratio (TTM) | 6.41 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.57% | N/A |
| ROE (TTM) | 13.69% | N/A |
| Net Profit Margin (TTM) | 4.96% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -2.20% | 105.92% | N/A |
| Revenue | 0.30% | 18.63% | N/A |
| Net Income | -3.75% | 117.86% | N/A |
| Cash Flow | -0.95% | 925.47% | N/A |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.17 | N/A |
| Quick Ratio (TTM) | 2.42 | N/A |
| D/E Ratio (TTM) | 5.48 | N/A |
| Interest Coverage (TTM) | 1.86 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.77 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |